Net Asset Value(s)

The table lists valuation data dated 02/10/2026 for three Pictet AI Enhanced equity ETFs. The USD funds show 2,840,000 units at NAV 10.719 for the US Equity UCITS ETF, 1,290,000 units at 10.5518 for the World Equity ETF USD Dis, and 29,620,000 units at 10.5514 for the World Equity ETF USD Acc.

Analysis

This is a fund-administration snapshot, not a signal on AI earnings, investor demand, or portfolio performance. A single NAV observation cannot establish returns, and the reported unit counts are not evidence of net flows without comparable prior-period figures and confirmation of what the counts represent. The “AI Enhanced” label also does not establish which securities or AI-related revenue exposures the portfolios hold; constituent and factor data are needed before drawing competitive or sector conclusions.

There is no defensible security-level trade from this disclosure alone. The near-term risk is misreading a valuation record as evidence of momentum or fund inflows. Over the next 1–3 months, the useful catalyst would be verified changes in assets and flows alongside holdings and benchmark-relative performance. A structural view would require evidence that the funds’ systematic selection process produces persistent exposure or performance differences—not merely an AI-branded mandate. Reassess if audited holdings, flow history, or performance attribution shows a material and sustained concentration in a specific AI supply-chain segment.

Key Decisions for Investors

• No trade on this item alone; do not infer AI-sector demand or ETF performance from one NAV date.
• Verify the unit-count definition, prior-period units/NAV, fund assets and net creations/redemptions before treating the snapshot as a flow signal.
• Request current holdings, benchmark, and performance attribution before mapping exposure to AI semiconductors, cloud infrastructure, or software; use those data to identify any actual overlap with existing positions.
• Revisit only if multi-period flow data and holdings confirm sustained exposure shifts or meaningful benchmark-relative performance; absent that evidence, the thesis is falsified as an actionable market signal.